{"id":"omega-3-fish-oil-lipid-emulsion","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypertriglyceridemia"},{"rate":null,"effect":"Infusion site reactions"},{"rate":null,"effect":"Gastrointestinal upset (if oral formulation)"},{"rate":null,"effect":"Bleeding tendency (at high doses)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Omega-3 fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are incorporated into cell membranes and act as precursors for anti-inflammatory mediators. They modulate inflammatory pathways, reduce triglycerides, and support cardiovascular and neurological health. The lipid emulsion formulation enables intravenous delivery for patients unable to receive oral supplementation.","oneSentence":"Omega-3 fish oil lipid emulsion provides essential polyunsaturated fatty acids (EPA and DHA) that reduce inflammation and support cellular function.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:24:16.184Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Parenteral nutrition supplementation in critically ill or post-operative patients"},{"name":"Prevention of essential fatty acid deficiency in patients unable to tolerate enteral feeding"}]},"trialDetails":[{"nctId":"NCT04031508","phase":"PHASE2","title":"Effect of a Parenteral Emulsion With Omega3 on Neonates With PPHN and CDH","status":"ENROLLING_BY_INVITATION","sponsor":"Coordinación de Investigación en Salud, Mexico","startDate":"2019-08-12","conditions":"Pulmonary Hypertension of Newborn, Diaphragm Defect","enrollment":40},{"nctId":"NCT07470892","phase":"","title":"Preoperative Fish Oil PN and Prognosis After Constipation Surgery","status":"NOT_YET_RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2026-03","conditions":"Constipation, Slow Transit Constipation, Megacolon","enrollment":306},{"nctId":"NCT06279793","phase":"PHASE2","title":"Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients","status":"RECRUITING","sponsor":"GCP-Service International West GmbH","startDate":"2024-02-15","conditions":"Intensive Care Unit, Coronary Artery Bypass Grafting (CABG), High Risk Patients","enrollment":550},{"nctId":"NCT06049680","phase":"PHASE4","title":"Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients","status":"RECRUITING","sponsor":"Fresenius Kabi","startDate":"2024-10-28","conditions":"Malnutrition, Child, Malnutrition, Essential Fatty Acid Deficiency (EFAD)","enrollment":100},{"nctId":"NCT07162688","phase":"PHASE1, PHASE2","title":"Effects of Omega-3 Fatty Acids on Acute Graft-versus-Host Disease After Allogeneic Stem Cell Transplantation.","status":"ENROLLING_BY_INVITATION","sponsor":"Fujian Medical University","startDate":"2025-05-16","conditions":"Graft-Versus-Host Disease(GVHD)","enrollment":30},{"nctId":"NCT02929303","phase":"","title":"Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD","status":"APPROVED_FOR_MARKETING","sponsor":"Wake Forest University Health Sciences","startDate":"","conditions":"Total Parenteral Nutrition-induced Cholestasis","enrollment":""},{"nctId":"NCT03869957","phase":"NA","title":"Effect of Parenteral Nutrition With n-3 PUFAs on Patients With Intestinal Failure","status":"COMPLETED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2019-12-01","conditions":"Intestinal Failure","enrollment":20},{"nctId":"NCT02512718","phase":"PHASE1","title":"Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell Transplantation","status":"COMPLETED","sponsor":"Alexandra N. Carey","startDate":"2016-06","conditions":"Hematopoietic Stem Cell Transplantation","enrollment":20},{"nctId":"NCT02412566","phase":"","title":"SMOF Lipid for Children With Parenteral Nutrition Induced Liver Injury","status":"APPROVED_FOR_MARKETING","sponsor":"Baylor College of Medicine","startDate":"","conditions":"Cholestasis, Growth Failure","enrollment":""},{"nctId":"NCT03387579","phase":"PHASE3","title":"Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical Neonates","status":"COMPLETED","sponsor":"Indiana University","startDate":"2018-11-30","conditions":"Cholestasis of Parenteral Nutrition","enrollment":24},{"nctId":"NCT03282955","phase":"PHASE4","title":"The HOME Study (HPN With OMEGA-3)","status":"COMPLETED","sponsor":"B. Braun Melsungen AG","startDate":"2018-01-08","conditions":"Patients Requiring Home Parenteral Nutrition","enrollment":74},{"nctId":"NCT03773237","phase":"NA","title":"Intralipid Versus SMOFlipid in HPN Patients","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2018-12-31","conditions":"Short Bowel Syndrome, Intestinal Fistula, Crohn Disease","enrollment":22},{"nctId":"NCT03857646","phase":"PHASE4","title":"The Effect of Lipid Emulsions on Free Fatty Acids and Free Bilirubin in Premature Newborns","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2019-03-02","conditions":"Prematurity","enrollment":66},{"nctId":"NCT06316362","phase":"PHASE2","title":"Efficacy of SMOF Lipid in the Management of Acute Poisoning With Carbamazepine","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-01-01","conditions":"Acute Poisoning","enrollment":40},{"nctId":"NCT00910104","phase":"PHASE2, PHASE3","title":"Cholestasis Reversal: Efficacy of IV Fish Oil","status":"COMPLETED","sponsor":"Mark Puder","startDate":"2006-08","conditions":"Parenteral Nutrition Associated Liver Disease, Short Bowel Syndrome, Gastrointestinal Disease","enrollment":91},{"nctId":"NCT06413589","phase":"PHASE2","title":"Efficacy of SMOF Lipid in the Management of Acute Poisoning With Clozapine","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-01-01","conditions":"Acute Poisoning","enrollment":40},{"nctId":"NCT02328768","phase":"","title":"Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in Children","status":"APPROVED_FOR_MARKETING","sponsor":"University of Nebraska","startDate":"","conditions":"Total Parenteral Nutrition-Induced Cholestasis","enrollment":""},{"nctId":"NCT00826020","phase":"PHASE2","title":"Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced Cholestasis","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2009-05-01","conditions":"Parenteral Nutrition Associated Liver Disease PNALD, Cholestasis","enrollment":72},{"nctId":"NCT04025021","phase":"NA","title":"Targeted Breast Milk Fortification for Very Low Birth Weight Infants in the NICU","status":"TERMINATED","sponsor":"MetroHealth Medical Center","startDate":"2019-10-01","conditions":"Human Milk, Neonate, Breast Milk","enrollment":3},{"nctId":"NCT02486042","phase":"PHASE2","title":"Omega-3 Long Chain Polyunsaturated Fatty Acid (LCPUFA) Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2014-03","conditions":"Retinopathy of Prematurity","enrollment":48},{"nctId":"NCT03563222","phase":"PHASE4","title":"Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age","status":"TERMINATED","sponsor":"Fresenius Kabi","startDate":"2019-12-18","conditions":"Malnutrition, Child","enrollment":1},{"nctId":"NCT01845116","phase":"PHASE2","title":"Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver Injury","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2010-07","conditions":"Total Parenteral Nutrition-induced Cholestasis","enrollment":11},{"nctId":"NCT02579265","phase":"PHASE3","title":"Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants","status":"TERMINATED","sponsor":"Fresenius Kabi","startDate":"2015-12","conditions":"Hospitalized Neonates and Infants, Expected to Require Parenteral Nutrition for 28 Days","enrollment":204},{"nctId":"NCT04957940","phase":"PHASE3","title":"Lipid Emulsion Infusion and COVID-19 Patients","status":"COMPLETED","sponsor":"Assiut University","startDate":"2021-07-05","conditions":"Covid19","enrollment":74},{"nctId":"NCT04697888","phase":"PHASE2, PHASE3","title":"Use of Omegaven for Treatment With Parenteral Nutrition Associated Liver Disease","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2013-04","conditions":"Parenteral Nutrition-related Hepatitis","enrollment":2},{"nctId":"NCT00497289","phase":"PHASE2","title":"Comparison of Two Different Lipid Emulsions for Parenteral Nutrition in Preterm Infants","status":"COMPLETED","sponsor":"B. Braun Melsungen AG","startDate":"2006-01","conditions":"Preterm Infants, Parenteral Nutrition n-3 Fatty Acids","enrollment":48},{"nctId":"NCT04511299","phase":"NA","title":"Impact of Fish Oil-enriched Lipid Emulsion on Fatty Acid and Inflammatory Response in Infants After Surgery","status":"COMPLETED","sponsor":"Dr. Soetomo General Hospital","startDate":"2020-04-07","conditions":"Surgery","enrollment":12},{"nctId":"NCT04467138","phase":"","title":"High Dose Intravenous Fish Oil Reduces Inflammation","status":"COMPLETED","sponsor":"Stanley Dudrick's Memorial Hospital","startDate":"2020-01-31","conditions":"Lipid Metabolism Disorders","enrollment":51},{"nctId":"NCT01173159","phase":"NA","title":"Compassionate Use of Omegaven to Reverse Parenteral Nutrition Induced Cholestasis","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2010-07","conditions":"Cholestasis","enrollment":10},{"nctId":"NCT04347902","phase":"PHASE4","title":"Lipid Emulsions and Liver Function - Results After 5 Years.","status":"COMPLETED","sponsor":"Stanley Dudrick's Memorial Hospital","startDate":"2016-01","conditions":"Liver Failure, Parenteral Nutrition-Related Hepatitis","enrollment":65},{"nctId":"NCT01323907","phase":"NA","title":"Compassionate Use of Omegaven IV Fat Emulsion","status":"WITHDRAWN","sponsor":"Sivan Kinberg","startDate":"2011-01","conditions":"Total Parenteral Nutrition-induced Cholestasis","enrollment":""},{"nctId":"NCT02370251","phase":"PHASE2, PHASE3","title":"Compassionate Use of Omegaven in Children","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2015-06","conditions":"Total Parenteral Nutrition-induced Cholestasis, Cholestasis, Short Bowel Syndrome","enrollment":63},{"nctId":"NCT03127345","phase":"PHASE2","title":"Omega 3 Fatty Acid Treatment for Pediatric Musculoskeletal Health","status":"WITHDRAWN","sponsor":"Boston Children's Hospital","startDate":"2019-09","conditions":"Esophageal Atresia","enrollment":""},{"nctId":"NCT01412359","phase":"","title":"Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Associated Hepatic Injury","status":"APPROVED_FOR_MARKETING","sponsor":"Jeffrey Rudolph","startDate":"","conditions":"Total Parenteral Nutrition-induced Cholestasis","enrollment":""},{"nctId":"NCT01194063","phase":"PHASE3","title":"Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children","status":"COMPLETED","sponsor":"Kapiolani Medical Center For Women & Children","startDate":"2010-10-20","conditions":"Cholestasis","enrollment":36},{"nctId":"NCT01425567","phase":"","title":"Compassionate Use of IV Fish Oil for Parenteral Nutrition (PN) Liver Injury","status":"APPROVED_FOR_MARKETING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"","conditions":"Liver Disease","enrollment":""},{"nctId":"NCT02010034","phase":"NA","title":"Compassionate Use of Omegaven in the Treatment of Parenteral Nutrition Induced Hepatic Injury","status":"COMPLETED","sponsor":"Children's Medical Center Dallas","startDate":"2013-08","conditions":"Liver Disease, Impaired Liver Function, Parenteral Nutrition Associated Liver Disease","enrollment":15},{"nctId":"NCT02925520","phase":"","title":"Expanded Access Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Liver Injury in Children","status":"NO_LONGER_AVAILABLE","sponsor":"Cook Children's Health Care System","startDate":"","conditions":"Parenteral Nutrition-Associated Liver Disease","enrollment":""},{"nctId":"NCT01325584","phase":"PHASE2","title":"Compassionate Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Hepatic Injury","status":"TERMINATED","sponsor":"Midwestern Regional Medical Center","startDate":"2012-10","conditions":"Cancer, Hepatic Injury","enrollment":12},{"nctId":"NCT03054948","phase":"PHASE4","title":"SMOFLipid in Patients Who Are Intralipid Intolerant","status":"WITHDRAWN","sponsor":"Mayo Clinic","startDate":"2017-02-01","conditions":"Home Parenteral Nutrition, Short Bowel Syndrome","enrollment":""},{"nctId":"NCT02550860","phase":"PHASE3","title":"Influence of Fish Oil Based Intravenous Fat Emulsions on the Epidermal Barrier Function","status":"TERMINATED","sponsor":"Hospices Civils de Lyon","startDate":"2015-01","conditions":"Intestinal Diseases","enrollment":13},{"nctId":"NCT02762539","phase":"NA","title":"Omega3 PUFA in Head Trauam","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2016-06","conditions":"Traumatic Brain Injury","enrollment":70},{"nctId":"NCT02633384","phase":"PHASE4","title":"Reduction of Neonatal Parenteral Nutrition Associated Cholestasis Through Lipid Emulsions","status":"TERMINATED","sponsor":"Centro Hospitalar de Lisboa Central","startDate":"2011-08","conditions":"Intrahepatic, Cholestasis","enrollment":52},{"nctId":"NCT02663453","phase":"PHASE3","title":"Effectiveness of Multicomponent Lipid Emulsion in Preterm Infants Requiring Parenteral Nutrition","status":"COMPLETED","sponsor":"Thammasat University","startDate":"2013-12","conditions":"Cholestasis","enrollment":44},{"nctId":"NCT03149653","phase":"PHASE4","title":"Crossover Study on the Effect of Omegaven in Combination With Different Lipid Emulsions in Home Parenteral Nutrition","status":"COMPLETED","sponsor":"General University Hospital, Prague","startDate":"2012-01-15","conditions":"Parenteral Nutrition","enrollment":24},{"nctId":"NCT02721277","phase":"PHASE1, PHASE2","title":"SMOFlipid to Lessen the Severity of Neonatal Cholestasis","status":"TERMINATED","sponsor":"University of Florida","startDate":"2016-05","conditions":"Cholestasis, Jaundice, Obstructive","enrollment":2},{"nctId":"NCT00047983","phase":"EARLY_PHASE1","title":"Omega-3 Fatty Acids That Affect the Immune System in Kidney Transplant Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Kidney Diseases","enrollment":75},{"nctId":"NCT01814956","phase":"PHASE4","title":"Different Lipid Emulsions in Acute Lung Injury Patients","status":"TERMINATED","sponsor":"B. Braun Melsungen AG","startDate":"2013-03","conditions":"Parenteral Nutrition","enrollment":1},{"nctId":"NCT01565278","phase":"PHASE3","title":"Fish Oil for Patients With Liver Disease Due to Parenteral Nutrition","status":"TERMINATED","sponsor":"Johane Allard","startDate":"2012-02","conditions":"Total Parenteral Nutrition-induced Cholestasis","enrollment":2},{"nctId":"NCT00516178","phase":"PHASE3","title":"Intravenous Fish Oil in Critically Ill Cardiac Patients","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Vaudois","startDate":"2008-01","conditions":"Coronary Artery Disease","enrollment":31},{"nctId":"NCT02349594","phase":"PHASE4","title":"Immune Modulation by Parenteral Fish Oil in Patients With Crohn's Disease","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2014-01","conditions":"Crohn Disease","enrollment":6},{"nctId":"NCT00533078","phase":"PHASE2","title":"Lipid Use, Nutrition, and Colitis in Patients With Hematological Malignancies","status":"COMPLETED","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2007-11","conditions":"Colitis, Mucositis, AML","enrollment":14},{"nctId":"NCT00534300","phase":"PHASE1, PHASE2","title":"Intravenous n-3 Fatty Acids and Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillator (ICD)-Pacemaker","status":"COMPLETED","sponsor":"Aalborg University Hospital","startDate":"2007-10","conditions":"Ventricular Tachycardia, Sudden Cardiac Death","enrollment":8},{"nctId":"NCT01175330","phase":"PHASE3","title":"Omega 3 Fatty Acid Efficiency for Prevention of Atrial Fibrillation After Coronary Artery Bypass Grafting","status":"TERMINATED","sponsor":"Meshalkin Research Institute of Pathology of Circulation","startDate":"2010-08","conditions":"Ischemic Heart Disease, Atrial Fibrillation","enrollment":39},{"nctId":"NCT01875510","phase":"NA","title":"The Influence of Fish-oil Lipid Emulsions on Neonatal Morbidities","status":"COMPLETED","sponsor":"Dr. Sami Ulus Children's Hospital","startDate":"2013-01","conditions":"Retinopathy of Prematurity, Neonatal Cholestasis","enrollment":80},{"nctId":"NCT00396461","phase":"PHASE4","title":"ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients","status":"TERMINATED","sponsor":"B. Braun Medical SA","startDate":"2006-11","conditions":"Critical Illness","enrollment":212},{"nctId":"NCT01819961","phase":"PHASE4","title":"Parenteral Fish Oil in Major Laparoscopic Abdominal Surgery","status":"UNKNOWN","sponsor":"Wei Zhou","startDate":"2013-04","conditions":"Gastric Tumor, Pancreatic Tumor, Liver Tumor","enrollment":50},{"nctId":"NCT01745861","phase":"PHASE2","title":"Effects Of Fish Oil Emulsion On Severe Acute Pancreatitis Patients","status":"COMPLETED","sponsor":"University Hospitals, Leicester","startDate":"2010-06","conditions":"Assess Effect of Omega-3 Fish Oil in Patients With Severe Acute Pancreatitis","enrollment":44},{"nctId":"NCT01176695","phase":"PHASE3","title":"Efficacy and Safety of a Fish Oil Containing Lipid Emulsion","status":"COMPLETED","sponsor":"B. Braun Melsungen AG","startDate":"2010-04","conditions":"Parenteral Nutrition","enrollment":240},{"nctId":"NCT00829569","phase":"NA","title":"n-3 Fatty Acid Infusion and Type 2 Diabetes","status":"COMPLETED","sponsor":"St. Olavs Hospital","startDate":"2004-01","conditions":"Type 2 Diabetes","enrollment":11},{"nctId":"NCT01048463","phase":"PHASE3","title":"Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2009-12","conditions":"Gastric Cancer, Colorectal Cancer, Chemotherapy","enrollment":90},{"nctId":"NCT01376817","phase":"PHASE4","title":"Comparative Study About the Impact of Two Oil Emulsions Administered Intravenously on Severe Acute Pancreatitis","status":"UNKNOWN","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2008-07","conditions":"Severe Acute Pancreatitis","enrollment":60},{"nctId":"NCT01218841","phase":"PHASE2","title":"Pure Fish Oil Parenteral Lipid Emulsion in Patients With Gastrointestinal Cancer","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2005-11","conditions":"Surgery","enrollment":85},{"nctId":"NCT00734916","phase":"NA","title":"Immune Modulation by Parenteral Lipids","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2008-08","conditions":"Infections, Total Parenteral Nutrition","enrollment":8},{"nctId":"NCT00600912","phase":"PHASE4","title":"Influence of of a Lipid Emulsion on Inflammatory Response and Hepatic Function","status":"COMPLETED","sponsor":"Klinikum Ludwigshafen","startDate":"2006-12","conditions":"Inflammatory Response, Hepatic Function","enrollment":42},{"nctId":"NCT00634075","phase":"PHASE4","title":"Clinical Assessment of Fish Oil-based Lipid Emulsion Infusions in Critical Patients With Severe Sepsis","status":"COMPLETED","sponsor":"Li Shin Hospital","startDate":"2008-03","conditions":"Severe Sepsis","enrollment":100},{"nctId":"NCT00336908","phase":"PHASE2, PHASE3","title":"Inflammatory Responses to Lipid Emulsions in Children Before and After Open Heart Surgery","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2005-11","conditions":"Inflammation, Cardiac Surgical Procedures","enrollment":32},{"nctId":"NCT00558155","phase":"PHASE4","title":"The Impact of Immunostimulating Nutrition on the Outcome of Surgery","status":"COMPLETED","sponsor":"Jagiellonian University","startDate":"2001-06","conditions":"Gastric Cancer, Pancreatic Cancer","enrollment":214}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Omegaven"],"phase":"phase_3","status":"active","brandName":"Omega-3 fish oil lipid emulsion","genericName":"Omega-3 fish oil lipid emulsion","companyName":"Kapiolani Medical Center For Women & Children","companyId":"kapiolani-medical-center-for-women-children","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Omega-3 fish oil lipid emulsion provides essential polyunsaturated fatty acids (EPA and DHA) that reduce inflammation and support cellular function. Used for Parenteral nutrition supplementation in critically ill or post-operative patients, Prevention of essential fatty acid deficiency in patients unable to tolerate enteral feeding.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}